Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease

31 May 2024

Description

To celebrate the FLOW trial and break down what it means for people with type 2 diabetes and CKD, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, recorded a special edition episode to discuss the clinical application of this trial, unmet need in CKD management, the future of incretin therapies, and more! Chapters: 00:00 - Intro  00:40 - FLOW Background 02:55 - FLOW Results 07:08 - Combination with SGLT2 Inhibitors 12:00 - Future Implications

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.